Disorders of Sex Differentiation

Published on 27/02/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2892 times

Chapter 125

Disorders of Sex Differentiation

Embryology, Sex Differentiation, and Gonad Differentiation

Overview: The three important precursor components needed for genital system development are the genital ridge and the two sets of internal sex ducts, the müllerian-paramesonephric and the wolffian-mesonephric. Around 7 weeks’ gestation, the embryologic genital ridge becomes either an ovary or a testis. The development of the male genital system is an “active” process requiring testes and müllerian inhibiting substance (MIS). The sex-determining region (SRY gene) on the Y chromosome’s short arm encodes a testis-determining factor. Under this factor’s influence (and in the presence of H-Y antigens found in the cell membranes of normal XY males) there is normal testis development with germ cells in the genital ridge differentiating into Sertoli cells and Leydig cells. Sertoli cells secrete MIS, which causes complete müllerian duct system involution. Leydig cells produce testosterone. The enzyme 5a-reductase converts testosterone intracellularly within the target tissues into the powerful androgen dihydrotestosterone (DHT). DHT allows the wolffian duct system to develop into the epididymis, vas deferens, ejaculatory duct, and seminal vesicles. If no Y chromosome exists or if abnormal encoding of testes determining factor is present, the gonad will passively differentiate into an ovary between 11 weeks to 17 weeks’ gestation in the presence of two X chromosomes. Absence of two X chromosomes may lead to abnormal or streak ovaries. The ovaries and their hormones, however, are thought to have no apparent role in sex differentiation of the female genital tract. The absence of MIS leads to persistence of müllerian structures, which develop into the fallopian tubes, uterus, cervix, and upper vagina. The wolffian ducts involute in the absence of testosterone. The undifferentiated external genitalia include the urogenital tubercle, urogenital swelling, and urogenital folds. DHT stimulation in males causes these structures to develop into the glans penis, scrotum, and penile shaft, respectively. In females, they develop into the clitoris, labia majora, and labia minora, respectively. The prostate gland develops from the urogenital sinus.16

Disorders of Sex Differentiation Without Ambiguity of External Genitalia (Box 125-1)

Phenotypic Female

Turner Syndrome (XO Gonadal Dysgenesis)

Overview: Classic Turner syndrome (isochromatous 45,XO karyotype pattern) is the most common gonadal dysgenesis associated with an abnormal karyotype in girls and is nonfamilial. A single X chromosome is the probable cause for the presence of streak ovaries (streaks or ridges of connective tissue in the mesosalpinges parallel to the fallopian tubes), rather than normal ovaries. Some functional ovarian elements are present in a few cases. Fallopian tubes, a uterus, and a vagina are present, and no wolffian duct derivatives are found.1,5,6

Patients with classic Turner syndrome have several somatic findings. Affected patients are short in stature, with a distinctive facies that includes low-set ears, a low hairline, and a high, arched palate. They have a short, broad, and webbed neck, widely spaced nipples, and a shield chest. Skeletal abnormalities are common—classically short fourth metacarpal, fifth metacarpal, or both. Cystic hygromas of the neck area are noted in fetal life; and the webbed neck is thought to be a residuum. Other variably seen findings include large aortic roots, coarctation of the aorta, renal anomalies (horseshoe kidneys), duplication anomalies, ureteropelvic junction obstruction, and Hashimoto thyroiditis. Patients with Turner syndrome have a history of delayed onset of puberty, no breast development or vaginal mucosal estrogenization (but presence of pubic and axillary hair), infantile internal and external genitalia, and primary amenorrhea.1,7,8

Imaging: The prepubertal uterus (Fig. 125-1) and vagina are normally formed and will respond to exogenous hormone stimulation. The dysgenetic or streak gonads are difficult to image. When the adnexa are measurable, they are typically less than 1 cm3 in volume.

Mosaic Turner Syndrome

One fourth of patients with 45,XO Turner syndrome have a so-called chromatin-positive pattern. Their karyotype is a mosaic consisting most often of a mixture of 45,XO and 46,XX chromosomes. Less often, other mosaic patterns (e.g., XO/XXX or XO/XX/XXX) or 46,XX and an abnormal X chromosome are present. In such cases, the gonads may consist of a streak ovary on one side and a hypoplastic or normal ovary on the other side, bilateral hypoplastic ovaries, or essentially normal ovaries. External and internal genitalia are entirely female, without wolffian duct remnants. These patients usually do not have the somatic abnormalities typically attributed to classic Turner syndrome, but many are short.1 Patients with mosaic Turner syndrome may develop secondary sex characteristics at puberty (found to occur in about 50%), and some may menstruate regularly.1,9

Phenotypic Males

Klinefelter Syndrome (47,XXY Seminiferous Tubular Dysgenesis)

Seminiferous tubular dysgenesis (Klinefelter syndrome) is the most common aberration of the human sex chromosome. The typical 47,XXY karyotype is found in phenotypic males with primary hypogonadism. It is nonfamilial, occurring in 1 in every 750 to 1000 males. Variants have been described with less common chromosomal abnormalities, including XX/XXY or XY/XXY mosaicism, as well as XXXY, XXXXY, XXYY, or XXXYY sex chromosomal karyotypes. The external genitalia, especially the testes, are small. The testes are usually less than 3 cm in length and are firm. Cryptorchidism and hypospadias are common, with future development of azoospermia and sterility in most patients. The diagnosis is usually not made until after puberty. Gynecomastia develops in almost half of the older patients, and affected patients (particularly those with the classic 47,XXY karyotype) are at an increased risk for breast cancer. Rare cases of testicular and extragonadal germ cell neoplasms have been reported.1,5,6

Disorders of Sex Differentiation with Ambiguous External Genitalia (Box 125-2)

Female Intersex

Overview: Female intersex is usually diagnosed in neonatal life in chromosomally normal females (46,XX) with masculinized external genitalia. The cause is usually increased fetal adrenal androgen production, most commonly from congenital adrenal hyperplasia or adrenogenital syndrome. Congenital adrenal hyperplasia (Fig. 125-2) is, by far, the most common cause of abnormal sex differentiation in females, occurring in 1 in 15,000 live births worldwide. It is caused by an inherited deficiency of enzymes involved in adrenocortical hormone biosynthesis. Affected patients have normal ovaries, a uterus, and fallopian tubes and no testicular tissue or internal wolffian duct derivatives. In most cases, the external genitalia are ambiguous (Fig. 125-3), with a prominent penis or partially fused labial scrotal folds.

Imaging: A variously sized vagina is connected with the posterior urethra, forming a urogenital sinus, which commonly empties at the base of the penis. No gonads can be palpated in the labioscrotal folds or in the inguinal canal of such patients because they are located within the pelvis. Voiding cystourethrography (VCUG) often shows a male-type elongated urethra (Fig. 125-4). These patients are potentially fertile with external genital reconstruction and correct sex assignment.1,2

Male Intersex

Male intersex patients are true males with a normal 46,XY male karyotype, present H-Y antigens, normal or mildly defective (and usually undescended) testes, but incomplete masculinization or frank ambiguity of their external genitalia. Decreased testosterone production and a lack of MIF production results in a karyotypically normal male with a female phenotype (except for partial masculinization of the external genitalia), and incomplete inhibition of the development of müllerian elements such as the uterus, vagina, and fallopian tubes (Fig. 125-5 and e-Fig. 125-6). Such patients usually have no secondary sexual development at puberty and may have an infantile uterus on ultrasonography. If the production of MIF by the testes is not affected, no internal müllerian system structures (uterus and fallopian tubes) will develop. The biochemical defect may be decreased androgen synthesis, decreased DHT production as a result of deficiency of 5a-reductase, or a defect in the androgen receptors. In many cases, the exact etiology remains unknown.1,2,5,6,12,13

Testicular Feminization Syndrome (Androgen Receptor Defect)

Testicular feminization syndrome (X-linked recessive) is a form of intersex in which patients with 46,XY karyotype have well-formed testes (usually undescended within the abdomen or inguinal region) that produce androgens and MIF. However, lack of end-organ response to androgens is caused by a defect in a specific cytoplasmic receptor protein (cytosol receptor) that normally binds DHT to the plasma membrane and transports it to the nuclear chromatin. Müllerian system development is inhibited, and patients do not develop a uterus, fallopian tubes, or the upper two thirds of the vagina. They do develop secondary female sexual characteristics via circulating estrogens (produced from the breakdown of testosterone and adrenal steroids as well as from direct production by the testes). Patients with the complete form of the abnormality appear as phenotypically normal females, although they may have inguinal or labial masses resulting from the undescended testes (Fig. 125-7). They have normal breast development and may or may not have a short, blind-ending vagina behind the urethral opening. They frequently present with amenorrhea and respond to substitutional estrogen therapy. In the incomplete form (10% to 20% of cases) of testicular feminization (incomplete androgen receptor defect), patients present earlier in life compared with those with the complete form and have ambiguous genitalia. Affected patients may have a predominantly female phenotype (incomplete testicular feminization) or a predominantly male phenotype (Reifenstein syndrome).1,2

Gonadal Dysgenesis

Mixed Gonadal Dysgenesis (Dysgenetic Male Pseudohermaphroditism)

Mixed or asymmetric gonadal dysgenesis (also known as XO/XY gonadal dysgenesis) is a relatively common form of abnormal sexual differentiation, usually occurring sporadically. Affected patient karyotypes are most often a mosaic of 45,XO and 46,XX. At times, XO/XYY or other mosaicisms are seen. These patients often have a streak gonad similar to that seen in Turner syndrome on one side and a usually dysgenetic (but occasionally normal) testis on the other. A fallopian tube is often present on the side of the streak gonad, and a vas deferens may be present on the side of the testis. The testis is usually intraabdominal but can be partially or completely descended. The external genitalia cover a wide spectrum of appearances from that of an almost normal female to that of an essentially normal male with hypospadias. Most patients have ambiguous external genitalia (as seen in other intersex situations), with a penis or clitoris of variable size, unfused labioscrotal folds, and a variously sized vagina connected with the urethra (urogenital sinus) that commonly empties at the base of the penis (Fig. 125-8). A uterus, said to be present in all cases, is usually small or rudimentary. Most patients are raised as females, but at puberty, some virilization may take place (usually without gynecomastia).1,2

Familial 46,XY Gonadal Dysgenesis

Familial 46,XY gonadal dysgenesis is an X-linked autosomal dominant trait associated with camptomelic dwarfism. The gonads are variable and may be bilateral streaks, bilateral dysgenetic testes, or a streak on one side and a dysgenetic testis on the other (mixed gonadal dysgenesis). Patients with bilateral streak gonads have a female phenotype with normal fallopian tubes, uterus, and vagina, usually clitoromegaly, and absence of wolffian duct derivatives. Sexual infantilism and amenorrhea are expected at puberty. Patients with bilateral dysgenetic testes or with a mixed form of gonadal dysgenesis typically have ambiguous or incompletely masculinized external genitalia. Müllerian and wolffian duct derivatives are present but may be hypoplastic or rudimentary.1,5,6

True Hermaphroditism

True hermaphroditism is a rare condition. It is a sporadic disorder in which the affected patient has both testicular and ovarian tissues in the same or contralateral gonads. More than half such patients have the 46,XX karyotype. Mosaic karyotype patterns with at least one line with a Y chromosome do exist, including XO/XY, XX/XXY, or XX/XY chimerism (30%). Fifteen percent of patients have the 46,XY karyotype. All true hermaphrodites are H-Y antigen positive regardless of karyotype. In patients with the 45,XX karyotype, undetected Y chromosomal material is probably present and transferred to another chromosome. The testes or ovotestes may be intraabdominal, in the inguinal region, in the scrotal area, or in the labia majora. The ovaries of hermaphrodites are almost always intraabdominal. Internal gonadal ducts are usually consistent with the ipsilateral gonad (i.e., a vas on the side of a testis and a fallopian tube on the side of an ovary). In the case of ovotestes, the associated internal gonadal duct is usually a fallopian tube. A uterus is found in almost all cases but is most often hypoplastic and may be bicornuate.1

A wide spectrum of external genitalia ranges from normal male to ambiguous to female. Cryptorchidism is common. Inguinal hernia is common as well and, as with normal patients, can contain a gonad with its internal gonadal duct or even a uterus. About 75% of hermaphrodites are brought up as males. At puberty, usually some virilization as well as gynecomastia occurs.1,2

Gonadal Neoplasia of Patients with Disorders of Sex Differentiation

The gonads in several intersex disorders (with or without ambiguous genitalia) are at an increased risk for developing neoplasms. Patients with the highest risk of developing gonadal neoplasia are those with XO/XY mixed gonadal dysgenesis and those with 46,XY gonadal dysgenesis. The incidence of a gonadal tumor in both these conditions increases from 3% to 4% by age 10 years to 10% to 20% within the second decade of life and to 70% or more in older patients. Neoplasms are almost always germ cell in type, including seminoma or dysgerminoma and gonadoblastoma. Less commonly, patients may develop a gonadal teratoma, teratocarcinoma, yolk sac tumor, embryonal carcinoma of the adult type, or choriocarcinoma. These neoplasms are rare in patients who do not have a Y chromosome as part of their karyotype. The risk is apparently related to the H-Y antigen.1,2

Diagnostic Evaluation of Patients with Ambiguous Genitalia

Overview: The discovery of anomalous or ambiguous genitalia in a newborn has been described as an emergency from a social perspective and, hence to many, from a clinical perspective as well. The identification of the uterus, vagina, or urogenital sinus, by using ultrasonography, contrast fistulogram, or vaginogram, is paramount in the decision on how to rear the child. These findings can then be correlated and sexual identification aided by karyotyping, including fluorescent studies for Y chromosomes, specific analysis of the Y chromosome for the testis-determining gene, culture of genital skin fibroblasts for androgen receptor binding, and tests for androgen responsiveness. The appearance of the external genitalia is seldom diagnostic of a specific intersex disorder, but palpable gonads in the inguinal canal, labioscrotal folds, or scrotum can exclude female pseudohermaphroditism in most cases. Sometimes, the definitive anatomic diagnosis is made only at laparoscopy or laparotomy and on the basis of gonadal biopsy. The main role of ultrasonography is identification of the uterus, a relatively easy task in the female newborn.1,2

Imaging: A detailed radiographic study of the lower genitourinary tract (genitography) is important for diagnosis and as a guide in surgical reconstructive procedures. Patients usually have a urogenital sinus, a common terminal channel for the anterior urethra and posterior vaginal pouch. This sinus usually empties at the base of the penis. VCUG, particularly on lateral view, may outline the entire anatomy needed for evaluation. If the urethral catheter can be advanced only to the vagina, an injection with the catheter in that position may opacify the vagina, the urogenital sinus, and often the proximal urethra. If confusion about the anatomy persists during the VCUG examination, a retrograde injection of contrast material may be attempted through a catheter with the tip placed just inside the “urethral” meatus. At times, a coude catheter (with a curved tip) manipulated under fluoroscopic control into the urethra and bladder or into the vagina may improve contrast study of the area. An effort should be made on the VCUG or vaginogram to determine if a uterine cervix is present. Often, if a uterus (especially if normal) is present, a mass impression of the cervix on the contrast medium–filled vagina (see Fig. 125-4) is evident. A cervical imprint, however, may not be apparent if the vagina is not sufficiently distended or if the uterus is hypoplastic. A uterine cervix is present in all female intersex patients and is a common finding among many patients with mixed gonadal dysgenesis or true hermaphroditism as well. All members of these groups may have a hypoplastic or rudimentary uterus that may not be noted radiographically. Cervical imprints are not seen in male pseudohermaphroditism or male hypospadias.1,2

In some patients evaluated by VCUG or contrast vaginogram, the urogenital sinus is quite short and joined by the vagina very close to the perineal surface (Fig. 125-9). In other patients, it is a much longer channel, joined by the vagina at a much higher level, occasionally near the bladder neck. A very high insertion of the vagina in the urogenital sinus may pose a problem at the time of vaginal reconstruction because of the danger of injuring the external urethral sphincter. In patients evaluated for disorders of sex differentiation or ambiguous genitalia, the vagina may vary in size from a small cavity to an organ of normal size for the patient’s age. Occasionally, its distal end is stenosed or is completely obliterated, resulting in hydrocolpos at birth or hematocolpos at puberty (Fig. 125-10).1

Pelvic ultrasonography is valuable in evaluating infants with ambiguous genitalia. Ultrasonography is an excellent imaging tool for identification of uterine tissue, although it may be difficult with hypoplastic uteri. The proximal vagina may also be demonstrated, particularly if it contains urine, but the urethra and urogenital sinus cannot be studied by this method. Ultrasonography does not replace genitography, but it is of particular value when genitography is unsuccessful. Ovaries are often seen, but fallopian tubes, unless obstructed, are more difficult to image. Ultrasonography is an excellent tool for the identification of the adrenal gland in the newborn and in the older child. Pelvic magnetic resonance imaging is of great value in evaluating patients with complex anatomy, particularly those with complex müllerian duct system abnormalities, in whom ultrasonography and genitography do not provide sufficient information (Fig. 125-11 and e-Fig. 125-12).1,1820

Suggested Readings

Ahmed, SF, Rodie, M. Investigation and initial management of ambiguous genitalia. Best Pract Res Clin Endocrinol Metab. 2010;24(2):197–218.

Barthold, JS. Disorders of sex differentiation: a pediatric urologist’s perspective of new terminology and recommendations. J Urol. 2011;185(2):393–400.

Chavhan, GB, Parra, DA, Oudjhane, K, et al. Imaging of ambiguous genitalia: classification and diagnostic approach. Radiographics. 2008;28(7):1891–1904.

Choi, HK, Cho, KS, Lee, HW, et al. MR imaging of intersexuality. Radiographics. 1998;18(1):83–96.

Cohen-Kettenis, PT. Psychosocial and psychosexual aspects of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2010;24(2):325–334.

Gillam, LH, Hewitt, JK, Warne, GL. Ethical principles for the management of infants with disorders of sex development. Horm Res Paediatr. 2010;74(6):412–418.

Lambert, SM, Vilain, EJ, Kolon, TF. A practical approach to ambiguous genitalia in the newborn period. Urol Clin North Am. 2010;37(2):195–205.

Vidal, I, Gorduza, DB, Haraux, E, et al. Surgical options in disorders of sex development (DSD) with ambiguous genitalia. Best Pract Res Clin Endocrinol Metab. 2010;24(2):311–324.

References

1. Cohen, HL. Anomalies of sex differentiation. In: Slovis T, ed. Caffey’s pediatric diagnostic imaging. 11th ed. Philadelphia, PA: Mosby (Elsvier); 2008:2394–2405.

2. Currarino, G, Wood, B, Majd, M. Abnormalities of the genital tract. In: Silverman F, Kuhn J, eds. Caffey’s pediatric x-ray diagnosis. 9th ed. St. Louis: Mosby–Year Book; 1993:1375–1401.

3. Rey, RA, Grinspon, RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 2011;25:221–238.

4. Kucinskas, L, Just, W. Human male sex determination and sexual differentiation: pathways, molecular interaction and genetic disorders. Medicina (Kaunas). 2005;41:633–640.

5. Purcell, K, Lingappa, V, Taylor, R. Disorders of the female reproductive tract. In: McPhee S, Ganong W, eds. Pathophysiology of disease. An introduction to clinical medicine. 5th ed. New York: McGraw-Hill; 2006:624–651.

6. McPhee, S. Disorders of the male reproductive tract. In: McPhee S, Ganong W, eds. Pathophysiology of disease. An introduction to clinical medicine. 5th ed. New York: McGraw-Hill; 2006:652–675.

7. Boechat, MI, Westra, SJ, Lippe, B. Normal US appearance of ovaries and uterus in four patients with Turner’s syndrome and 45,X karyotype. Pediatr Radiol. 1996;26:37–39.

8. Nidecker, A, Cohen, HL, Zinn, HL. Amenorrhea in the adolescent or young adult. In: Bluth E, Benson C, Ralls P, et al, eds. Ultrasound. A practical approach to clinical problems. 2nd ed. New York: Thieme; 2008:513–527.

9. Hall, JG, Gilchrist, DM. Turner syndrome and its variants. Pediatr Clin North Am. 1990;37:1421–1440.

10. Fernandes, E, Fernandes, E, Hollabaugh, S, et al. Persistent müllerian duct syndrome. Urology. 1990;36:516–518.

11. Halbertsma, F, Otten, B, Wijnen, R, et al. A baby boy with cryptorchism, inguinal hernia and internal female genitalia: the persistent Müllerian duct syndrome. Ned Tijdschr Geneeskd. 2004;148:484–487.

12. Sivit, CJ, Hung, W, Taylor, G, et al. Sonography in neonatal congenital adrenal hyperplasia. AJR Am J Roentgenol. 1991;156:141–143.

13. Speiser, P. Prenatal treatment of congenital adrenal hyperplasia. J Urol. 1999;162:534–536.

14. Koziell, A, Grundy, R. Frasier and Denys-Drash syndromes: different disorders or part of a spectrum? Arch Dis Child. 1999;81(4):365–369.

15. Coppes, MJ, Huff, V, Pelletier, J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr. 1993;123(5):673–678.

16. Marcantonio, SM, Fechner, PY, Migeon, CJ, et al. Embryonic testicular regression sequence: a part of the clinical spectrum of 46,XY gonadal dysgenesis. Am J Med Genet. 1994;49:1–5.

17. de la Chapelle, A. The etiology of maleness in XX men. Hum Genet. 1981;58:105–116.

18. Cohen, HL, Bober, S, Bow, S. Imaging the pediatric pelvis: the normal and abnormal genital tract and simulators of its diseases. Urol Radiol. 1992;14:273–283.

19. Ratani, R, Cohen, HL, Fiore, E. Pediatric gynecologic ultrasound. Ultrasound Q. 2004;20:127–139.

20. Cohen, HL, Lemond, T. Gynecologic imaging of the pediatric patient. In: Fielding J, Brown D, Thurmond A, eds. Gynecologic imaging. Philadelphia: Elsevier Saunders; 2011:547–564.

Share this: